These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16516100)

  • 1. Pathophysiology of stent thrombosis: platelet activation, mechanical factors, or both?
    Alfonso F
    J Am Coll Cardiol; 2006 Mar; 47(5):1086-7; author reply 1087. PubMed ID: 16516100
    [No Abstract]   [Full Text] [Related]  

  • 2. A thromboxane A2/prostaglandin H2 receptor antagonist (S18886) shows high antithrombotic efficacy in an experimental model of stent-induced thrombosis.
    Vilahur G; Casaní L; Badimon L
    Thromb Haemost; 2007 Sep; 98(3):662-9. PubMed ID: 17849057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor.
    Gurbel PA
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S20-8. PubMed ID: 17224887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis.
    Buonamici P; Marcucci R; Migliorini A; Gensini GF; Santini A; Paniccia R; Moschi G; Gori AM; Abbate R; Antoniucci D
    J Am Coll Cardiol; 2007 Jun; 49(24):2312-7. PubMed ID: 17572245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction.
    Lev EI; Alviar CL; Arikan ME; Dave BP; Granada JF; DeLao T; Tellez A; Maresh K; Kleiman NS
    Am Heart J; 2007 Jan; 153(1):41.e1-6. PubMed ID: 17174635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet hyperactivity and risk of recurrent thrombosis.
    Harrison P; Keeling D
    J Thromb Haemost; 2006 Dec; 4(12):2544-6. PubMed ID: 17026648
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet activation and stent thrombosis.
    Georgiadou P; Voudris V
    Hellenic J Cardiol; 2017; 58(1):49-50. PubMed ID: 28396052
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
    van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
    Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombin as a common downstream target blocking both platelet and monocyte activation.
    Santilli F; Davì G
    Thromb Haemost; 2009 Feb; 101(2):220-1. PubMed ID: 19190800
    [No Abstract]   [Full Text] [Related]  

  • 10. [Platelet inhibition and activation. Mechanisms and clinical implications].
    Alberio L; Clemetson KJ
    Herz; 2005 May; 30(3):176-80. PubMed ID: 15902367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late stent thrombosis in drug-eluting stents: return of the 'VB syndrome'.
    Serruys PW; Kukreja N
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):637. PubMed ID: 17122790
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-eluting stent thrombosis.
    Stähli BE; Camici GG; Tanner FC
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to thrombotic events is achievable if we stop the guessing game: is this the major hidden message from GRAVITAS?
    Gurbel PA; Tantry US; Bliden KP; Jeong YH
    Thromb Haemost; 2011 Aug; 106(2):263-4. PubMed ID: 21544320
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients.
    Gurbel PA; DiChiara J; Tantry US
    Am J Cardiol; 2007 Oct; 100(8B):18M-25M. PubMed ID: 17950828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stent thrombosis: it's never too late.
    Kandzari DE
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):638-9. PubMed ID: 17122791
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of stents in the current era: long-term antiplatelet therapy and late-stent thrombosis.
    Buxton B
    ANZ J Surg; 2008; 78(1-2):2-5. PubMed ID: 18199197
    [No Abstract]   [Full Text] [Related]  

  • 17. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
    Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
    Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of platelet hyper-reactivity measured with a portable device immediately after percutaneous coronary intervention predicts in stent thrombosis.
    Jacopo G; Elisabetta V; Silverio S; Massimiliano M; Sergio B; Grazia AM; Philippe CJ
    Thromb Res; 2007; 121(3):407-12. PubMed ID: 17555804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis.
    Takemoto Y; Kawata H; Soeda T; Imagawa K; Somekawa S; Takeda Y; Uemura S; Matsumoto M; Fujimura Y; Jo J; Kimura Y; Tabata Y; Saito Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):857-62. PubMed ID: 19325141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stent thrombosis with drug-eluting stents: a re-examination of the evidence.
    Kedia G; Lee MS
    Catheter Cardiovasc Interv; 2007 May; 69(6):782-9. PubMed ID: 17394249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.